Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction.: A randomized, double-blind, placebo-controlled clinical trial" (Am Heart J 2006; 152:887.e9-14)

被引：0
|
作者：
Vydt, Tom [1 ]
Agostoni, Pierfrancesco
机构：
[1] Univ Hosp Leuven, Dept Cardiol, Louvain, Belgium
[2] Antwerp Cardiovasc Inst Middelheim, Antwerp, Belgium
来源：
AMERICAN HEART JOURNAL | 2007年 / 153卷 / 05期
关键词：
D O I：
10.1016/j.ahj.2007.01.015
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 22 条
  • [1] Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction.: A randomized, double-blind, placebo-controlled clinical trial" (Am Heart J 2006; 152:887.e9-14) -: Response
    Amit, Guy
    Zahger, Doron
    AMERICAN HEART JOURNAL, 2007, 153 (05)
  • [2] Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial
    Amit, Guy
    Cafri, Carlos
    Yaroslavtsev, Sergei
    Fuchs, Shmuel
    Paltiel, Ora
    Abu-Ful, Akram
    Weinstein, Jean M.
    Wolak, Arik
    Ilia, Reuben
    Zahger, Doran
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 887.e9 - 887.e14
  • [3] No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial)
    Zhang Hai-tao
    Jia Zhen-hua
    Zhang Jian
    Ye Zan-kai
    Yang Wei-xian
    Tian Yue-qin
    Jia Xuan
    Li Wei
    Wu Yi-ling
    Yang Yue-jin
    CHINESE MEDICAL JOURNAL, 2010, 123 (20) : 2858 - 2864
  • [4] A randomized, double-blind assessment of intracoronary sodium nitroprusside, verapamil, and normal saline for the treatment of microvascular spasm after direct percutaneous coronary intervention for acute myocardial infarction.
    Kanani, RS
    Lundberg, D
    Alnaeemi, A
    Faris, P
    Goodhart, DM
    Traboulsi, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 233E - 234E
  • [5] Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol
    Niccoli, Giampaolo
    D'amario, Domenico
    Spaziani, Cristina
    Cosentino, Nicola
    Marino, Marcello
    Rigattieri, Stefano
    Lo Schiavo, Paolo
    De Vita, Maria Rosaria
    Tarantino, Fabio
    Bartorelli, Antonio
    Fabbiocchi, Franco
    Prati, Francesco
    Imola, Fabrizio
    Valgimigli, Marco
    Ferrari, Roberto
    Crea, Filippo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2009, 10 (07) : 585 - 592
  • [6] Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction The REOPEN-AMI Study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)
    Niccoli, Giampaolo
    Rigattieri, Stefano
    De Vita, Maria Rosaria
    Valgimigli, Marco
    Corvo, Pierfrancesco
    Fabbiocchi, Franco
    Romagnoli, Enrico
    De Caterina, Alberto Ranieri
    La Torre, Giuseppe
    Lo Schiavo, Paolo
    Tarantino, Fabio
    Ferrari, Roberto
    Tomai, Fabrizio
    Olivares, Paolo
    Cosentino, Nicola
    D'Amario, Domenico
    Leone, Antonio Maria
    Porto, Italo
    Burzotta, Francesco
    Trani, Carlo
    Crea, Filippo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (06) : 580 - 589
  • [7] A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction
    Jang, Ik-Kyung
    Senatore, Fred
    Weisman, Neil
    Picard, Michael H.
    Zile, Michael R.
    Pettigrew, Veronica
    Shen, Steven
    Tatsuno, Jun
    Hibberd, Mark
    Wackers, Frans J. Th
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 241A - 241A
  • [8] Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
    Huang, Dong
    Qian, Juying
    Liu, Zongjun
    Xu, Yawei
    Zhao, Xianxian
    Qiao, Zengyong
    Fang, Weiyi
    Jiang, Li
    Hu, Wei
    Shen, Chengxing
    Liang, Chun
    Zhang, Qi
    Ge, Junbo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] Rationale and design of the RIGHT trial: A multicenter, randomized, double-blind, placebo-controlled trial of anticoagulation prolongation versus no anticoagulation after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
    Yan, Yan
    Wang, Xiao
    Guo, Jincheng
    Li, Yongjun
    Ai, Hui
    Gong, Wei
    Que, Bin
    Zhen, Lei
    Lu, Jiapeng
    Ma, Changsheng
    Montalescot, Gilles
    Nie, Shaoping
    AMERICAN HEART JOURNAL, 2020, 227 : 19 - 30
  • [10] Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    Armstrong, PW
    Adams, PX
    Al-Khalidi, HR
    Hamm, C
    Holmes, D
    O'Neill, W
    Todaro, TG
    Vahanian, A
    Van de Werf, F
    Granger, CB
    AMERICAN HEART JOURNAL, 2005, 149 (03) : 402 - 407
123